Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews
- PMID: 30629654
- PMCID: PMC6328162
- DOI: 10.1371/journal.pone.0210312
Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews
Abstract
Introduction: Medication review (MR) is a pharmacy practice conducted in different settings that has a positive impact on patient health outcomes. In this context, systematic reviews on MR have restricted the assessment of this practice using criteria such as methodological quality, practice settings, and patient outcomes. Therefore, expanding research on this subject is necessary to facilitate the understanding of the effectiveness of MR and the comparison of its results.
Aim: To examine the panorama of systematic reviews on pharmacist-participated MR in different practice settings.
Methods: A literature search was undertaken in Biblioteca Virtual em Saúde (BVS), Embase, PubMed, Scopus, The Cochrane Library, and Web of Science databases through January 2018 using keywords for "medication review", "systematic review", and "pharmacist". Two independents investigators screened titles, abstracts, full texts; assessed methodological quality; and, extracted data from the included reviews.
Results: Seventeen systematic reviews were included, of which sixteen presented low to moderate methodological quality. Most of reviews were conducted in Europe (n = 7), included controlled primary studies (n = 16), elderly patients (n = 9), and long-term care facilities (n = 8). Seven reviews addressed MR as an intervention and thirteen reviews cited collaboration between physicians and pharmacists in the practice of MR. In addition, thirteen terminologies for MR were used and the main objective was to identify and solve drug-related problems and/or optimize the drug use (n = 11).
Conclusion: There is considerable heterogeneity in practice settings, population, definitions, terminologies, and approach of MR as well as poor description of patient care process in the systematic reviews. These facts may limit the comparison, summarization and understanding of the results of MR. Furthermore, the methodological quality of most systematic reviews was below ideal. Thus, international agreement on the MR process is necessary to assess, compare and optimize the quality of care provided.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Pharmaceutical Care Network Europe. Medication review definition approved. 2016 Feb 20 [cited 10 March 2016]. In: Pharmaceutical Care Network Europe Website [Internet]. Europe: Pharmaceutical Care Network Europe (PCNE) 2016. http://www.pcne.org/news/35/medication-review-definition-approved.
-
- Clyne W, Blenkinsopp A, Seal R. A guide to medication review. London: National Prescribing Centre (NPC), 2008.
-
- Pharmacy Council of New Zealand. Medicines management: definition, levels, competence framework. Wellington: Pharmacy Council of New Zealand; 2006.
-
- American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;48(3): 341–353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
